Better protection of patents and R&D, in Canada, will boost the business relations with the U.S.
Global Innovation Policy Center (GIPC) @globalIPcenter 1h
"Instead of expanding on [the TRIPS] waiver, the U.S. should be bolstering #IP rights to encourage the research and creation of new cures and medicines." Insight via @MinnRepublic. https://t.co/sca1v3JSsT